Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study

Publication date: 2016 Source:Breast Diseases: A Year Book Quarterly, Volume 27, Issue 1 Author(s): L.J. Solin
Source: Breast Diseases: A Year Book Quarterly - Category: Cancer & Oncology Source Type: research